Lataa...
Use and delivery of granulocyte colony–stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy—single-centre experience
BACKGROUND: Use of granulocyte colony-stimulating factor (g-csf) as primary prophylaxis against chemotherapy-induced neutropenia has significant cost implications. We examined use of g-csf for early-stage breast cancer patients at our centre. The study also examined the pattern of nurse-led patient...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Multimed Inc.
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410835/ https://ncbi.nlm.nih.gov/pubmed/22876152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.948 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|